Advertisement
Screener

TRACON Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities

TRACON Pharmaceuticals, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities

TRACON Pharmaceuticals, Inc. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $7.49 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:InterestPaidNet · last filed 2024-03-05

  • TRACON Pharmaceuticals, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2023 was $7.49M, a 1986.63% increase from fiscal 2022.
  • TRACON Pharmaceuticals, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2022 was $359.00K, a 34.96% increase from fiscal 2021.
  • TRACON Pharmaceuticals, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2021 was $266.00K, a 39.95% decline from fiscal 2020.
  • TRACON Pharmaceuticals, Inc. interest paid, excluding capitalized interest, operating activities for fiscal 2020 was $443.00K, a 27.61% decline from fiscal 2019.
Period endInterest Paid, Excluding Capitalized Interest, Operating Activities 12 month
2023-12-31$7.49M
10-K · filed 2024-03-05
2022-12-31$359.00K
10-K · filed 2024-03-05
2021-12-31$266.00K
10-K · filed 2024-03-05
2020-12-31$443.00K
10-K · filed 2023-03-08
2019-12-31$612.00K
10-K · filed 2022-03-15
2018-12-31$642.00K
10-K · filed 2021-02-25
2017-12-31$664.00K
10-K · filed 2020-02-28
2016-12-31$622.00K
10-K · filed 2019-03-01
2015-12-31$428.00K
10-K · filed 2018-03-01
2014-12-31$270.00K
10-K · filed 2017-03-01
2013-12-31$4.00K
10-K · filed 2016-02-19